Cancer cells express aberrant DNMT3B transcripts encoding truncated proteins
暂无分享,去创建一个
M. L. Beau | E. Davis | L. Godley | K. R. Ostler | S. L. Payne | B. B. Gosalia | J. Expósito-Céspedes | Kelly R. Ostler | Lucy A. Godley | Elizabeth M. Davis | S. L. Payne | Lucy A. Godley
[1] Diane D. Liu,et al. Expression of ΔDNMT3B Variants and Its Association with Promoter Methylation of p16 and RASSF1A in Primary Non–Small Cell Lung Cancer , 2006 .
[2] S. Jang,et al. A novel DNMT3B subfamily, DeltaDNMT3B, is the predominant form of DNMT3B in non-small cell lung cancer. , 2006, International journal of oncology.
[3] M. Grever,et al. Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms. , 2006, Cancer research.
[4] S. Stamm,et al. Splicing factor Tra2-beta1 is specifically induced in breast cancer and regulates alternative splicing of the CD44 gene. , 2006, Cancer research.
[5] Christian B. Woods,et al. Quantitative analysis of associations between DNA hypermethylation, hypomethylation, and DNMT RNA levels in ovarian tumors , 2006, Oncogene.
[6] R. Jaenisch,et al. Suppression of Intestinal Neoplasia by Deletion of Dnmt3b , 2006, Molecular and Cellular Biology.
[7] E. Li,et al. Roles for Dnmt3b in mammalian development: a mouse model for the ICF syndrome , 2006, Development.
[8] A. Chan. E-cadherin in gastric cancer. , 2006, World journal of gastroenterology.
[9] P. Guldberg,et al. Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early‐stage patients , 2006, European journal of haematology.
[10] A. Stein,et al. Histone H1 Depletion in Mammals Alters Global Chromatin Structure but Causes Specific Changes in Gene Regulation , 2005, Cell.
[11] S. Matsui,et al. Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells. , 2005, Cancer research.
[12] T. Rowlands,et al. Cadherins and catenins in breast cancer. , 2005, Current opinion in cell biology.
[13] R. Jaenisch,et al. Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[14] K. Robertson. DNA methylation and human disease , 2005, Nature Reviews Genetics.
[15] J. Venables. Aberrant and Alternative Splicing in Cancer , 2004, Cancer Research.
[16] K. Robertson,et al. DNMT3B interacts with hSNF2H chromatin remodeling enzyme, HDACs 1 and 2, and components of the histone methylation system. , 2004, Biochemical and biophysical research communications.
[17] Keith D Robertson,et al. Isolation and characterization of a novel DNA methyltransferase complex linking DNMT3B with components of the mitotic chromosome condensation machinery. , 2004, Nucleic acids research.
[18] M. Ehrlich. The ICF syndrome, a DNA methyltransferase 3B deficiency and immunodeficiency disease. , 2003, Clinical immunology.
[19] R. Hansen,et al. X inactivation-specific methylation of LINE-1 elements by DNMT3B: implications for the Lyon repeat hypothesis. , 2003, Human molecular genetics.
[20] M. Schrappe,et al. Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia , 2003, Nature.
[21] O. Haas,et al. Differential methylation pattern of the X-linked lymphoproliferative (XLP) disease gene SH2D1A correlates with the cell lineage-specific transcription , 2003, Immunogenetics.
[22] R. Jaenisch,et al. Chromosomal Instability and Tumors Promoted by DNA Hypomethylation , 2003, Science.
[23] S. Hirohashi,et al. Mutation of the DNA methyltransferase (DNMT) 1 gene in human colorectal cancers. , 2003, Cancer letters.
[24] K. Maruyama,et al. The human DNA methyltransferases DNMT3A and DNMT3B have two types of promoters with different CpG contents. , 2002, Biochimica et biophysica acta.
[25] Y. Fukushima,et al. Three novel DNMT3B mutations in Japanese patients with ICF syndrome. , 2002, American journal of medical genetics.
[26] E. Li. Chromatin modification and epigenetic reprogramming in mammalian development , 2002, Nature Reviews Genetics.
[27] M. Caligiuri,et al. RasGRP4 Is a Novel Ras Activator Isolated from Acute Myeloid Leukemia* , 2002, The Journal of Biological Chemistry.
[28] K. Robertson. DNA methylation and chromatin – unraveling the tangled web , 2002, Oncogene.
[29] C. J. Barnes,et al. A naturally occurring MTA1 variant sequesters oestrogen receptor-α in the cytoplasm , 2002, Nature.
[30] M. Robert,et al. An Essential Role for DNA Methyltransferase DNMT3B in Cancer Cell Survival* , 2002, The Journal of Biological Chemistry.
[31] R. Roberts,et al. Co‐operation and communication between the human maintenance and de novo DNA (cytosine‐5) methyltransferases , 2002, The EMBO journal.
[32] A. Sali,et al. RasGRP4, a New Mast Cell-restricted Ras Guanine Nucleotide-releasing Protein with Calcium- and Diacylglycerol-binding Motifs , 2002, Journal of Biological Chemistry.
[33] S. Hirohashi,et al. Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[34] T. Cooper,et al. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. , 2002, Molecular cell.
[35] H. Taubert,et al. Alternative and aberrant splicing of MDM2 mRNA in human cancer. , 2002, Cancer cell.
[36] A. Shyu,et al. RNA surveillance by nuclear scanning? , 2002, Nature Cell Biology.
[37] Bert Vogelstein,et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells , 2002, Nature.
[38] M. Maio,et al. Promoter Methylation Controls the Expression of MAGE2, 3 and 4 Genes in Human Cutaneous Melanoma , 2002, Journal of immunotherapy.
[39] J. Chung,et al. Dnmt3b, de novo DNA methyltransferase, interacts with SUMO-1 and Ubc9 through its N-terminal region and is subject to modification by SUMO-1. , 2001, Biochemical and biophysical research communications.
[40] J. Herman,et al. DNA methylation, chromatin inheritance, and cancer , 2001, Oncogene.
[41] T. Bestor,et al. The DNA methyltransferases of mammals. , 2000, Human molecular genetics.
[42] J. Herman,et al. CpG methylation is maintained in human cancer cells lacking DNMT1 , 2000, Nature.
[43] C. Wijmenga,et al. The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[44] N. Tommerup,et al. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene , 1999, Nature.
[45] D. Haber,et al. DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian Development , 1999, Cell.
[46] M. Culbertson,et al. RNA surveillance. Unforeseen consequences for gene expression, inherited genetic disorders and cancer. , 1999, Trends in genetics : TIG.
[47] S. Clark,et al. High sensitivity mapping of methylated cytosines. , 1994, Nucleic acids research.
[48] Rudolf Jaenisch,et al. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality , 1992, Cell.
[49] M. Robert,et al. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells , 2003, Nature Genetics.
[50] J. Herman,et al. Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. , 2003, Cancer cell.
[51] D. Riesner,et al. Induction of Tumors in Mice by Genomic Hypomethylation , 2003 .
[52] C. J. Barnes,et al. A naturally occurring MTA1 variant sequesters oestrogen receptor-alpha in the cytoplasm. , 2002, Nature.
[53] K. Robertson,et al. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. , 1999, Nucleic acids research.